MMV390048

MMV390048 · Medicines for Malaria Venture

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for MMV390048, covering 2017-02-08 to 2021-12-09. Get the full timeline:

Most recent: Clinical Trial Update: MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria [Phase 2]